TY - JOUR
T1 - Expanding the neurodevelopmental phenotype of PURA syndrome
AU - Lee, Bo Hoon
AU - Reijnders, Margot R.F.
AU - Abubakare, Oluwatobi
AU - Tuttle, Emily
AU - Lape, Brynn
AU - Minks, Kelly Q.
AU - Stodgell, Christopher
AU - Bennetto, Loisa
AU - Kwon, Jennifer
AU - Fong, Chin To
AU - Gripp, Karen W.
AU - Marsh, Eric D.
AU - Smith, Wendy E.
AU - Huq, Ahm M.
AU - Coury, Stephanie A.
AU - Tan, Wen Hann
AU - Solis, Orestes
AU - Mehta, Rupal I.
AU - Leventer, Richard J.
AU - Baralle, Diana
AU - Hunt, David
AU - Paciorkowski, Alex R.
N1 - Funding Information:
We wish to acknowledge the PURA Syndrome foundation, as well as the families of our research subjects. Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under award numbers K08NS078054 (to A.R.P.) and K08NS089830 (to R.I.M.), and the National Institute for Deafness and Communications Disorders R01DC009439 (to L.B.). We would also like to acknowledge the University of Rochester Genomics Research Center for sequencing support, and the University of Rochester Center for Integrated Research Computing for providing high-performance computing resources.
Publisher Copyright:
© 2017 Wiley Periodicals, Inc.
PY - 2018/1
Y1 - 2018/1
N2 - PURA syndrome is a recently described developmental encephalopathy presenting with neonatal hypotonia, feeding difficulties, global developmental delay, severe intellectual disability, and frequent apnea and epilepsy. We describe 18 new individuals with heterozygous sequence variations in PURA. A neuromotor disorder starting with neonatal hyptonia, but ultimately allowing delayed progression to walking, was present in nearly all individuals. Congenital apnea was present in 56% during infancy, but all cases in this cohort resolved during the first year of life. Feeding difficulties were frequently reported, with gastrostomy tube placement required in 28%. Epilepsy was present in 50% of the subjects, including infantile spasms and Lennox–Gastaut syndrome. Skeletal complications were found in 39%. Disorders of gastrointestinal motility and nystagmus were also recurrent features. Autism was diagnosed in one individual, potentially expanding the neurodevelopmental phenotype associated with this syndrome. However, we did not find additional PURA sequence variations in a cohort of 120 subjects with autism. We also present the first neuropathologic studies of PURA syndrome, and describe chronic inflammatory changes around the arterioles within the deep white matter. We did not find significant correlations between mutational class and severity, nor between location of the sequence variation in PUR repeat domains. Further studies are required in larger cohorts of subjects with PURA syndrome to clarify these genotype–phenotype associations.
AB - PURA syndrome is a recently described developmental encephalopathy presenting with neonatal hypotonia, feeding difficulties, global developmental delay, severe intellectual disability, and frequent apnea and epilepsy. We describe 18 new individuals with heterozygous sequence variations in PURA. A neuromotor disorder starting with neonatal hyptonia, but ultimately allowing delayed progression to walking, was present in nearly all individuals. Congenital apnea was present in 56% during infancy, but all cases in this cohort resolved during the first year of life. Feeding difficulties were frequently reported, with gastrostomy tube placement required in 28%. Epilepsy was present in 50% of the subjects, including infantile spasms and Lennox–Gastaut syndrome. Skeletal complications were found in 39%. Disorders of gastrointestinal motility and nystagmus were also recurrent features. Autism was diagnosed in one individual, potentially expanding the neurodevelopmental phenotype associated with this syndrome. However, we did not find additional PURA sequence variations in a cohort of 120 subjects with autism. We also present the first neuropathologic studies of PURA syndrome, and describe chronic inflammatory changes around the arterioles within the deep white matter. We did not find significant correlations between mutational class and severity, nor between location of the sequence variation in PUR repeat domains. Further studies are required in larger cohorts of subjects with PURA syndrome to clarify these genotype–phenotype associations.
KW - PURA
KW - congenital apnea
KW - deletion 5q31.3
KW - epilepsy
KW - intellectual disability
UR - http://www.scopus.com/inward/record.url?scp=85034259928&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.38521
DO - 10.1002/ajmg.a.38521
M3 - Article
C2 - 29150892
AN - SCOPUS:85034259928
VL - 176
SP - 56
EP - 67
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
SN - 1552-4825
IS - 1
ER -